论文部分内容阅读
选择两组人群对照实施化疗两年，计算各项成本、费用，并用ｋａｔｏ法考核，两年后两组人群感染率分别下降６９．３７％和５６．７５％（Ｐ＞０．０５），两组实施成本分别为１４．２６／人和９．７０元／人，单位效果成本，第一年目标化疗组是群体化疗组的１．４倍，第二年群体化疗组是目标化疗组的１．８倍。结果表明在较高感染率水平（１２％以上）的人群中第一年宜采用群体化疗，在保证化疗质量和足够覆盖面的前提下，第二年应改用目标化疗。
Two groups of patients were selected to receive chemotherapy for two years. The costs and expenses were calculated. The kato test was used to evaluate the two groups. After two years, the infection rates of the two groups decreased by 69.37% and 56.75% (P> 0.05) Group implementation costs were 14.26 / person and 9.70 yuan / person, unit cost of effectiveness, the first year of the target chemotherapy group was 1.4 times the chemotherapy group, the second year of the group chemotherapy is the target chemotherapy group 1 .8 times. The results showed that in the first year of the population with higher infection rate (above 12%), group chemotherapy should be adopted. In the second year, targeted chemotherapy should be used instead of chemotherapy in order to ensure the quality of chemotherapy and sufficient coverage.